Dihydro‐resveratrol ameliorates NLRP3 inflammasome‐mediated neuroinflammation via Bnip3‐dependent mitophagy in Alzheimer's disease
In summary, these findings suggest that dihydro-resveratrol (DHR) possesses potent anti-neuroinflammatory property and can act as a potential therapeutic agent for the treatment of AD.
Authors
- Xuebao Wang (ORCID: https://orcid.org/0000-0002-5944-7603)
- Saidan Ding (ORCID: https://orcid.org/0000-0003-1658-2319)
- Yiru Ye (ORCID: https://orcid.org/0000-0003-4087-8400)
- Guorong Tao
- Minxue Zhang
- Jian Wang (ORCID: https://orcid.org/0000-0002-9482-5227)
- Lang Yan (ORCID: https://orcid.org/0000-0002-9252-0841)
Institutions
- Shanghai Jiao Tong University (CN)
- Fudan University (CN)
- Wenzhou Medical University (CN)
- Ruijin Hospital (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Hubei Polytechnic University (CN)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1111/bph.17373
- Citations
- 25
- Primary Topic
- Autophagy in Disease and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 9.67